A Study to Describe the Switching From a First- or Second-line Disease Modifying Therapy (DMT) to Ozanimod in Participants With Relapsing Remitting Multiple Sclerosis (RRMS)
N/A
The purpose of this study is to describe the reasons, therapy, and/or disea...
Status
Completed
Location
Local Institution - 0001
Start Date
2023-07-14
Trial ID
NCT05658601
SUPERSTAR: Aspiration vs. Stent Retriever in Anterior Circulation LVO
NA
This is a multicenter, open-label, blinded-endpoint, randomized controlled ...
'COMBINE-2': Real-world Evidence for Effectiveness of Two Drug Regimen, Antiretroviral Therapy With Integrase Inhibitors Plus a Reverse Transcriptase Inhibitor
N/A
Dolutegravir (DTG) is a well-tolerated 2nd generation integrase strand tran...